These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 24301687

  • 1. Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.
    Jardin CG, Putney D, Michaud S.
    Ann Pharmacother; 2014 Feb; 48(2):196-202. PubMed ID: 24301687
    [Abstract] [Full Text] [Related]

  • 2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross-Sectional Study of Adult Inpatients.
    Shao W, Ayub S, Drutel R, Heise WC, Gerkin R.
    J Clin Psychopharmacol; 2019 Jul; 39(1):72-77. PubMed ID: 30531476
    [Abstract] [Full Text] [Related]

  • 5. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P, Hreiche R, Turgeon J.
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W.
    Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC, Bauman JL.
    Pharmacotherapy; 1995 Jan; 15(6):687-92. PubMed ID: 8602374
    [Abstract] [Full Text] [Related]

  • 9. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M, Belhassen B, Hochenberg M, Viskin S.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):320-8. PubMed ID: 17239713
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC.
    Psychosomatics; 2013 Jan 23; 54(1):1-13. PubMed ID: 23295003
    [Abstract] [Full Text] [Related]

  • 12. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V.
    Int J Clin Pharm; 2016 Apr 23; 38(2):310-20. PubMed ID: 26749342
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA, Eckerman KM, Jacob KA, Pawlaski EM, Wigersma SK, Marienau ME, Oliver WC, Narr BJ, Ackerman MJ.
    Anesthesiology; 2007 Oct 23; 107(4):531-6. PubMed ID: 17893447
    [Abstract] [Full Text] [Related]

  • 17. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
    Das B, Rawat VS, Ramasubbu SK, Kumar B.
    Therapie; 2019 Dec 23; 74(6):599-609. PubMed ID: 31053339
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J, Baldinger SH, Goodman-Meza D, Engstrom K, Valencia CR, Golive A, Medrano F, Rangasamy S, Makkiya M, Fisher JD, Gross J, Krumerman A, Kim S, Garcia MJ, Di Biase L, Ferrick KJ.
    J Interv Card Electrophysiol; 2016 Jan 23; 45(1):37-45. PubMed ID: 26589717
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.
    Al-Azayzih A, Al-Qerem W, Al-Azzam S, Muflih S, Al-Husein BA, Kharaba Z, Kanaan RJ, Rahhal D.
    Vasc Health Risk Manag; 2024 Jan 23; 20():27-37. PubMed ID: 38318252
    [Abstract] [Full Text] [Related]

  • 20. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G, Carmel NN, Lotan D, Kremer A, Justo D.
    Z Gerontol Geriatr; 2018 Jan 23; 51(1):41-47. PubMed ID: 27878411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.